JP2007535548A5 - - Google Patents

Download PDF

Info

Publication number
JP2007535548A5
JP2007535548A5 JP2007510941A JP2007510941A JP2007535548A5 JP 2007535548 A5 JP2007535548 A5 JP 2007535548A5 JP 2007510941 A JP2007510941 A JP 2007510941A JP 2007510941 A JP2007510941 A JP 2007510941A JP 2007535548 A5 JP2007535548 A5 JP 2007535548A5
Authority
JP
Japan
Prior art keywords
methyl
isochroman
piperidin
aminomethyl
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007510941A
Other languages
English (en)
Japanese (ja)
Other versions
JP4685861B2 (ja
JP2007535548A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/014487 external-priority patent/WO2005111025A1/en
Publication of JP2007535548A publication Critical patent/JP2007535548A/ja
Publication of JP2007535548A5 publication Critical patent/JP2007535548A5/ja
Application granted granted Critical
Publication of JP4685861B2 publication Critical patent/JP4685861B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007510941A 2004-04-29 2005-04-27 ドーパミンアゴニストとしての3−ピペリジニルイソクロマン−5−オール Expired - Fee Related JP4685861B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56655704P 2004-04-29 2004-04-29
PCT/US2005/014487 WO2005111025A1 (en) 2004-04-29 2005-04-27 3-piperidinylisochroman-5-ols as dopamine agonists

Publications (3)

Publication Number Publication Date
JP2007535548A JP2007535548A (ja) 2007-12-06
JP2007535548A5 true JP2007535548A5 (enExample) 2008-03-27
JP4685861B2 JP4685861B2 (ja) 2011-05-18

Family

ID=34967397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007510941A Expired - Fee Related JP4685861B2 (ja) 2004-04-29 2005-04-27 ドーパミンアゴニストとしての3−ピペリジニルイソクロマン−5−オール

Country Status (11)

Country Link
US (1) US7919508B2 (enExample)
EP (1) EP1749001B1 (enExample)
JP (1) JP4685861B2 (enExample)
AR (1) AR050245A1 (enExample)
AT (1) ATE459618T1 (enExample)
DE (1) DE602005019719D1 (enExample)
DK (1) DK1749001T3 (enExample)
ES (1) ES2342083T3 (enExample)
PT (1) PT1749001E (enExample)
TW (1) TW200607802A (enExample)
WO (1) WO2005111025A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014339136C1 (en) * 2013-10-22 2019-10-31 Chiesi Farmaceutici S.P.A. Process for the preparation of a PDE4 inhibitor
CA2946990A1 (en) * 2014-04-28 2015-11-05 Pfizer Inc. Heterocyclic compounds and their use as dopamine d1 ligands
EA035544B1 (ru) * 2014-10-08 2020-07-03 Юсб Байофарма Спрл Производные тетрагидроизохинолина
BR112019001407A2 (pt) 2016-07-29 2019-07-09 Sunovion Pharmaceuticals Inc. compostos e composições e usos dos mesmos
SG10202100724UA (en) * 2016-07-29 2021-03-30 Sunovion Pharmaceuticals Inc Compounds and compositions and uses thereof
AU2017311691B2 (en) 2016-08-18 2021-12-02 Vidac Pharma Ltd. Piperazine derivatives, pharmaceutical compositions and methods of use thereof
MX2020000523A (es) * 2017-08-02 2020-08-20 Sunovion Pharmaceuticals Inc Compuestos de isocromano y usos de los mismos.
CN111196781B (zh) * 2018-11-16 2023-07-28 湖南中南制药有限责任公司 一种改进的制备五氟利多的方法
JP7703449B2 (ja) 2019-03-14 2025-07-07 スミトモ・ファーマ・アメリカ・インコーポレイテッド イソクロマニル化合物の塩およびその結晶体、ならびにそれらの製造方法、治療用途および医薬組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963568A (en) * 1989-05-31 1990-10-16 Abbott Laboratories Dopamine agonists
US4994486A (en) * 1989-05-31 1991-02-19 Abbott Laboratories Dopaminergic compounds
ES2194303T3 (es) * 1997-02-07 2003-11-16 Aventis Pharma Inc Derivados de (4-piperidinil)-1h-2-benzopirano utiles como agentes antipsicoticos.
US6004982A (en) * 1997-09-15 1999-12-21 Hoechst Marion Roussel, Inc. 4-piperidinyl) H-2-benzopyran derivatives useful as antipsychotic agents

Similar Documents

Publication Publication Date Title
JP6466171B2 (ja) 新規アミン誘導体またはその塩
KR102491308B1 (ko) Cyp11a1 (시토크롬 p450 모노옥시게나제 11a1) 억제제로서 피란 유도체
AU2012266369B2 (en) Pyridin- 2 -amides useful as CB2 agonists
KR101477553B1 (ko) 이소인돌론 화합물 및 대사성 글루타메이트 수용체증강제로서 이들의 용도
AU732863B2 (en) Indole derivatives having combined 5HT1A, 5HT1B and 5HT1D receptor antagonist activity
PT808312E (pt) Derivados de indolo antagonistas do receptor 5-ht
EP2033953A1 (en) Vanilloid receptor modulators
PT1492786E (pt) Piridinoilpiperidinas como agonistas do 5-ht1f
JP2006298893A5 (enExample)
BRPI0609062A2 (pt) composição farmacêutica, compostos, método para o tratamento terapêutico e/ou profilático de enfermidades que são moduladas por inibidores de deidrogenase de hidroxiesteróide-11ß e utilização dos compostos
KR20060095865A (ko) 글리신 수송 억제제로서의 비시클릭 [3.1.0] 유도체
JP2008501691A (ja) 化学化合物および炎症性疾患を処置するためにその化学化合物を含む薬学的組成物
CZ289998B6 (cs) Léčivo proti nachlazení nebo alergické rinitidě
WO2005115977A1 (en) Pyrrolidine derivatives as cb1-receptor antagonists
CA2538381A1 (en) 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3)
WO2014003124A1 (ja) 新規なアミド誘導体またはその塩
CA2092112A1 (en) Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use
CA2525442A1 (en) Cyanofluoropyrrolidine derivatives
JPH09500124A (ja) 5‐ht1a受容体拮抗物質としてのn‐(ピペリジニル‐1‐アルキル)‐置換シクロヘキサンカルボン酸アミド
JP2004504318A (ja) 置換1−(4−アミノフェニル)インドール類及びその抗炎症剤としての使用
JP5410536B2 (ja) 3−(ベンジルアミノ)−ピロリジン誘導体及びnk−3受容体アンタゴニストとしてのその使用
CN102834385B (zh) 1型11-β-羟基固醇脱氢酶的抑制剂化合物
CN1323297A (zh) 哒嗪酮衍生物
CA2470214A1 (en) 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
JPWO2000023436A1 (ja) キナゾリノン誘導体